ASCO 2024 Clinical Results
Our study shows the technical feasibility of integrating functional precision [...]
Biomarker Development for Pharmaceutical Companies and Patients
Our studies demonstrate the potential for predictive and generative artificial [...]
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling-
Function Precision Medicine (FPM) and AI to provide new treatment [...]
Probabilistic Boolean Modeling of Pre-clinical Tumor Models for Biomarker Identification in Cancer Drug Development
As high-throughput sequencing experiments become more widely used in pre-clinical [...]
Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma
Nonrhabdomyosarcoma soft-tissue sarcomas (STSs) are a class of 50+ cancers [...]
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Cancer patients with advanced disease routinely exhaust available clinical regimens [...]
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Diffuse intrinsic pontine glioma (DIPG) is a fatal childhood cancer. [...]